151 related articles for article (PubMed ID: 10807049)
1. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.
Haus O
Arch Immunol Ther Exp (Warsz); 2000; 48(2):95-100. PubMed ID: 10807049
[TBL] [Abstract][Full Text] [Related]
2. IRF-1 induced cell growth inhibition and interferon induction requires the activity of the protein kinase PKR.
Kirchhoff S; Koromilas AE; Schaper F; Grashoff M; Sonenberg N; Hauser H
Oncogene; 1995 Aug; 11(3):439-45. PubMed ID: 7543195
[TBL] [Abstract][Full Text] [Related]
3. Expression of the protein kinase PKR in modulated by IRF-1 and is reduced in 5q- associated leukemias.
Beretta L; Gabbay M; Berger R; Hanash SM; Sonenberg N
Oncogene; 1996 Apr; 12(7):1593-6. PubMed ID: 8622878
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
5. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
[TBL] [Abstract][Full Text] [Related]
6. Integrin alpha 11 is a novel type I interferon stimulated gene.
Leomil Coelho LF; Mota BE; Sales PC; Marques JT; de Oliveira JG; Bonjardim CA; Peregrino Ferreira PC; Kroon EG
Cytokine; 2006 Mar; 33(6):352-61. PubMed ID: 16697656
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the interferon system, immune response and oncogenesis by the transcription factor interferon regulatory factor-1.
Taniguchi T; Tanaka N; Taki S
Eur Cytokine Netw; 1998 Sep; 9(3 Suppl):43-8. PubMed ID: 9831185
[TBL] [Abstract][Full Text] [Related]
8. [Interferon].
Tanaka H
Gan To Kagaku Ryoho; 1997 Sep; 24(11):1471-6. PubMed ID: 9309144
[TBL] [Abstract][Full Text] [Related]
9. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
[TBL] [Abstract][Full Text] [Related]
10. Tumour necrosis factor-alpha and interferon-gamma synergistically activate the RANTES promoter through nuclear factor kappaB and interferon regulatory factor 1 (IRF-1) transcription factors.
Lee AH; Hong JH; Seo YS
Biochem J; 2000 Aug; 350 Pt 1(Pt 1):131-8. PubMed ID: 10926836
[TBL] [Abstract][Full Text] [Related]
11. Type I interferon response against viral and non-viral gene transfer in human tumor and primary cell lines.
Rautsi O; Lehmusvaara S; Salonen T; Häkkinen K; Sillanpää M; Hakkarainen T; Heikkinen S; Vähäkangas E; Ylä-Herttuala S; Hinkkanen A; Julkunen I; Wahlfors J; Pellinen R
J Gene Med; 2007 Feb; 9(2):122-35. PubMed ID: 17191255
[TBL] [Abstract][Full Text] [Related]
12. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
13. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
Kröger A; Dallügge A; Kirchhoff S; Hauser H
Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
[TBL] [Abstract][Full Text] [Related]
14. The murine PKR tumor suppressor gene is rearranged in a lymphocytic leukemia.
Abraham N; Jaramillo ML; Duncan PI; Méthot N; Icely PL; Stojdl DF; Barber GN; Bell JC
Exp Cell Res; 1998 Nov; 244(2):394-404. PubMed ID: 9806790
[TBL] [Abstract][Full Text] [Related]
15. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
16. [Interferons in hemato-cancerology].
Boiron M
Nouv Rev Fr Hematol (1978); 1987; 29(1):49-55. PubMed ID: 2438645
[TBL] [Abstract][Full Text] [Related]
17. [Interferon and diseases].
Kita M
Rinsho Byori; 1994 Aug; 42(8):860-6. PubMed ID: 7523746
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomic analyses on interferon-lambdas and their roles in cancer prediction.
Yang L; Wei J; He S
Int J Mol Med; 2010 Feb; 25(2):299-304. PubMed ID: 20043142
[TBL] [Abstract][Full Text] [Related]
19. Interferons.
Morris AG
Immunol Suppl; 1988; 1():43-5. PubMed ID: 2454889
[TBL] [Abstract][Full Text] [Related]
20. The increase in levels of interferon-inducible proteins p202a and p202b and RNA-dependent protein kinase (PKR) during myoblast differentiation is due to transactivation by MyoD: their tissue distribution in uninfected mice does not depend on interferons.
Wang H; Ding B; Liu CJ; Ma XY; Deschamps S; Roe BA; Lengyel P
J Interferon Cytokine Res; 2002 Jun; 22(6):729-37. PubMed ID: 12162885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
